文献速递肾移植肾小球疾病

供者HLA-D与PLA2R1风险等位基因与肾移植后原发性膜性肾病复发相关

HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
PubMed 文献 · Kidney Int · 2020-09-02

该研究在248例原发性膜性肾病患者中鉴定出HLA-D和PLA2R1位点的风险单核苷酸多态性(SNP),并在105对供受者回顾性队列及40对验证队列中分析其与移植后复发的关联。结果显示供者携带的HLA-D和PLA2R1风险SNP可预测复发,基于四个SNP的遗传风险评分可识别高复发风险患者。

要点

  • 供者HLA-D和PLA2R1风险SNP与移植后原发性膜性肾病复发相关。
  • 基于rs9271705、rs9271550、rs17830558和rs3828323的风险评分可识别高复发风险。
  • 遗传检测用于供者选择前仍需进一步研究。

核心结论

  • 移植肾通过疾病易感性HLA-D和PLA2R1 SNP在自身免疫环境中促进原发性膜性肾病复发。

研究设计与样本

  • 研究对248例原发性膜性肾病患者进行PLA2R1和HLA-D位点测序以鉴定风险SNP。
  • 在105对供受者回顾性队列和40对验证队列中分析风险变异与复发的关联。

主要发现

  • 移植后原发性膜性肾病复发率高达44%,且由PLA2R抗体驱动。
  • HLA-D位点鉴定出rs9271188和rs9275086,PLA2R1位点鉴定出rs6726925和rs13018963为风险SNP。
  • 与rs9271188连锁不平衡的7个HLA-DRB1-HLA-DQA1间SNP和3个PLA2R1区域SNP在供者携带时预测复发,受者携带时无预测作用。
  • 与复发关联最强的两个HLA-D区SNP(rs9271705和rs9271550)在验证队列中得到确认。
  • 基于rs9271705、rs9271550、rs17830558和rs3828323的遗传风险评分可识别高复发风险患者组。

临床怎么用

  • 供者HLA-D和PLA2R1风险SNP检测有望辅助评估移植后原发性膜性肾病复发风险。
  • 基于四个SNP的遗传风险评分可用于识别高复发风险患者,但实施前需进一步研究。

局限性

  • 遗传检测用于供者选择前仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recurrence of primary membranous nephropathy after transplantation occurs in up to 44% of patients and is driven by PLA2R antibody. Here, we asked whether genetic determinants could improve risk prediction. First, we sequenced PLA2R1 and HLA-D loci in 248 patients with primary membranous nephropathy and identified two independent single nucleotide polymorphisms (SNPs) at risk for primary membranous nephropathy at each locus. These were rs9271188 (intergenic between HLA-DRB1 and HLA-DQA1,) and rs9275086 (intergenic between HLA-DQB1 and HLA-DQA2) at the HLA-D locus along with rs6726925 and rs13018963 at the PLA2R1 locus. Then we investigated whether primary membranous nephropathy at-risk variants were associated with recurrence in a retrospective cohort of 105 donor-recipient pairs and a replication cohort of 40 pairs. Seven SNPs located between HLA-DRB1 and HLA-DQA1 in linkage disequilibrium with rs9271188, and three SNPs in the PLA2R1 region predicted recurrence when presented by the donor, but not when presented by the recipient. The two SNPs in the HLA-D region most strongly associated with recurrence (rs9271705 and rs9271550) were confirmed in the replication cohort. A genetic risk score based on the two best predictors at each locus (rs9271705, rs9271550, rs17830558, and rs3828323) identified a group of patients with high risk of recurrence. Thus, our results suggest that the graft contributes to recurrence of primary membranous nephropathy through the disease susceptibility HLA-D and PLA2R1 SNPs in an autoimmune milieu. Further studies are needed before implementation of genetic testing for these in donor selection.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2020. PMID: 32889013. doi:10.1016/j.kint.2020.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。